scispace - formally typeset
M

M. Grieco

Researcher at University of Naples Federico II

Publications -  44
Citations -  4819

M. Grieco is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Thyroid carcinoma & Thyroid. The author has an hindex of 27, co-authored 44 publications receiving 4720 citations. Previous affiliations of M. Grieco include Mediterranea University of Reggio Calabria.

Papers
More filters
Journal ArticleDOI

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

TL;DR: A novel activated oncogene resulted from the rearrangement of an unknown amino-terminal sequence to the tyrosine kinase domain of the ret proto-oncogene and was detected by transfection analysis in five out of 20 primary human thyroid papillary carcinomas and in the available lymph node metastases.
Journal ArticleDOI

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

TL;DR: Oncogenic conversion of RET in these neoplastic syndromes establishes germline transmission of dominant transforming genes in human cancer.
Journal ArticleDOI

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

TL;DR: The detection of transforming activity in DNAs extracted from five thyroid papillary carcinomas and two of their respective lymph-nodal metastases is reported.
Journal Article

Molecular characterization of RET/PTC3; A novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma

TL;DR: The identification and cloning of a novel rearranged version of the RET oncogene in a human thyroid papillary carcinoma and evidence indicating that the rearrangement leading to the generation of RET/PTC3 occurred in vivo in the original tumor DNA is provided.
Journal Article

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

TL;DR: Since both PTC, a novel rearranged form of RET, and TRK display a tyrosine protein kinase activity, it is proposed that the activation of this class of oncogenes is specifically involved in the pathogenesis of papillary thyroid cancer.